We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.5B
AUM Growth
+$857M
Cap. Flow
+$670M
Cap. Flow %
14.88%
Top 10 Hldgs %
17.64%
Holding
512
New
198
Increased
109
Reduced
79
Closed
118

Top Buys

Rank Stock Value
1
AMSG
Amsurg Corp
AMSG
+$73.5M
2
RCAP
RCS CAPITAL CORPORATION CLASS A COM
RCAP
+$39.5M
3
VISN
Vistance Networks Inc
VISN
+$37.4M
4
MHK icon
Mohawk Industries
MHK
+$36.3M
5
ARMK icon
Aramark
ARMK
+$31.5M

Top Sells

Rank Stock Value
1
PF
Pinnacle Foods, Inc.
PF
+$34.3M
2
PFE icon
Pfizer
PFE
+$32.3M
3
ROK icon
Rockwell Automation
ROK
+$31.2M
4
FRX
FOREST LABORATORIES INC
FRX
+$31.1M
5
NFLX icon
Netflix
NFLX
+$28.2M

Sector Composition

Rank Sector Weight
1 Healthcare 13.99%
2 Industrials 12.65%
3 Financials 10.63%
4 Consumer Discretionary 9.16%
5 Energy 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMPR
351
DELISTED
IMPRIVATA, INC COM
IMPR
$1.03M 0.02%
+63,095
New +$1.02M
META icon
352
Meta Platforms (Facebook)
META
$1.51T
$1.01M 0.02%
+15,000
New +$923K
AMPH icon
353
Amphastar Pharmaceuticals
AMPH
$916M
$1M 0.02%
+100,000
New +$982K
MOBL
354
DELISTED
MobileIron, Inc.
MOBL
$952K 0.02%
+100,000
New +$1.01M
ADMS
355
DELISTED
Adamas Pharmaceuticals
ADMS
$918K 0.02%
+50,201
New +$899K
MTLS
356
Materialise
MTLS
$396M
$863K 0.02%
+75,000
New +$879K
PSG
357
DELISTED
Performance Sports Group Ltd.
PSG
$858K 0.02%
+50,000
New +$850K
SEMI
358
DELISTED
SunEdison Semiconductor Limited
SEMI
$809K 0.02%
+47,813
New +$788K
VNDA icon
359
Vanda Pharmaceuticals
VNDA
$302M
$800K 0.02%
+49,466
New +$659K
CVRR
360
DELISTED
CVR Refining, LP
CVRR
$792K 0.02%
31,680
-160,000
-83% -$4.09M
EVAR
361
DELISTED
Lombard Medical, Inc.
EVAR
$785K 0.02%
+109,034
New +$888K
ALDR
362
DELISTED
Alder Biopharmaceuticals
ALDR
$778K 0.02%
+38,744
New +$546K
ZPIN
363
DELISTED
Zhaopin Limited
ZPIN
$775K 0.02%
+50,476
New +$759K
RLJE
364
CALL
DELISTED
RLJ Entertainment, Inc.
RLJE
$764K 0.02%
66,667
– –
XNET
365
Xunlei
XNET
$326M
$749K 0.02%
+50,000
New +$754K
NSLR
366
Neostellar Capital Corp
NSLR
$254M
$744K 0.02%
+108,477
New +$677K
TBRA
367
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$740K 0.02%
12,109
-27,345
-69% -$1.66M
BMY icon
368
Bristol-Myers Squibb
BMY
$132B
$728K 0.02%
15,000
-152,362
-91% -$7.51M
DOC
369
DELISTED
PHYSICIANS REALTY TRUST
DOC
$712K 0.02%
+49,466
New +$676K
ENZY
370
DELISTED
Enzymotec Ltd
ENZY
$703K 0.02%
51,840
-133,693
-72% -$2.24M
INSY
371
DELISTED
Insys Therapeutics, Inc.
INSY
$686K 0.02%
+43,914
New +$710K
WBA
372
DELISTED
Walgreens Boots Alliance
WBA
$681K 0.02%
+9,191
New +$642K
QNST icon
373
QuinStreet
QNST
$1.21B
$680K 0.02%
123,369
+10,984
+10% +$63.4K
GEVO icon
374
CALL
Gevo
GEVO
$382M
$602K 0.01%
117
– –
LINC icon
375
Lincoln Educational Services
LINC
$1.3B
$535K 0.01%
+119,156
New +$472K
13 14
15
16 17

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2014 Portfolio in Review

As of Q2 2014, Alyeska Investment Group held 512 positions worth $4.5B, up 24% from $3.64B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $670M of net new capital in Q2 2014, opening 198 new positions and adding to 109 existing holdings. Its largest new stake was Amsurg Corp: 1,600,000 shares worth $72.9M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Pinnacle Foods, Inc., an estimated $34.3M trimmed.

  • Alyeska Investment Group's largest Q2 2014 buy was Amsurg Corp: 1,600,000 shares worth $72.9M.
  • Alyeska Investment Group added most to Capital One in Q2 2014, an estimated $18.5M increase.
  • Alyeska Investment Group's biggest Q2 2014 reduction was Pinnacle Foods, Inc., cutting an estimated $34.3M.
  • Alyeska Investment Group fully exited Pfizer in Q2 2014, selling an estimated $32.3M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $4.5B portfolio in Q2 2014.
  • Alyeska Investment Group opened 198 new positions and closed 118 in Q2 2014.
  • Alyeska Investment Group's portfolio value rose 24% quarter-over-quarter to $4.5B.

Based on Alyeska Investment Group's 13F filing for Q2 2014, filed 14 Aug 2014.